Incyte Corporation Sustains Strong Momentum with Robust Financials and Advancing Pipeline, Solidifying Biotech Leadership
Wilmington, Delaware – September 23, 2026 – Incyte Corporation (NASDAQ: INCY), a global biopharmaceutical leader headquartered in Wilmington, Delaware, continues to demonstrate exceptional financial performance and strategic prowess, buoyed by…
